Pediatric Indication for Teflaro Pending FDA Review
February 16th 2016The FDA is reviewing Allergan's supplemental new drug application for ceftaroline fosamil to treat children aged 2 months and older with acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia.
Read More